🇧🇸
Peptide Laws in Bahamas
BS · Americas · 23 peptides tracked
LegalEnforcement: Lenient
Are Peptides Legal in Bahamas?
The Bahamas has a British-influenced pharmaceutical framework through PHA with low enforcement, benefiting from a tourism-driven economy. Research peptides are not widely available locally, but the relaxed regulatory environment means personal-use imports are unlikely to face problems. Basic prescription medications are accessible at pharmacies. There is no established peptide clinic scene.
23
Grey AreaCan You Buy Peptides in Bahamas?
23 peptide(s) fall into a legal grey area: Tirzepatide, Selank, MOTS-c, TB-500, GHK-Cu, and 18 more. These may be available for research purposes but their legality for personal use is ambiguous.
Traveling to Bahamas with Peptides
When traveling to Bahamas with peptides, the legality depends on each peptide's classification. Enforcement in Bahamas is rated as "Lenient." Always declare pharmaceutical products at customs and carry documentation of any prescriptions.
New to peptides? Start with the basics on peptide.camp →
Need to source peptides for Bahamas? Get verified wholesale quotes on peptide.broker →
Traveling to Bahamas with peptides? TSA tips, packing guides & the peptide travel case on peptide.travel →
Peptide Regulations in Bahamas
| Peptide | Status | Rx Required | Schedule | Detail | Source |
|---|---|---|---|---|---|
| Tirzepatide | Grey Area | Yes | No Product Registration Regime | The Bahamas has NO drug marketing-authorisation system. The Pharmacy Act, Ch. 227 (Act No. 8 of 2009) registers people and premises and licenses manufacturers and wholesalers, but does not require a product to be approved before sale - claims that the Bahamas operates drug registration are incorrect. What binds instead: s.27 requires every drug manufactured, offered for sale, imported or exported to meet a pharmacopoeial standard (BP, USP, Ph. Eur., Int. Ph. or another approved by the Minister), with a fine up to BSD 20,000 - a research-grade peptide with no pharmacopoeial monograph fails that test. Section 28 refers import and export control to the Customs Management Act rather than medicines law. Section 33 requires factory and warehouse registration for manufacture or import for storage and wholesale distribution, fine up to BSD 15,000. Note also s.30(5): a prescription expressly does NOT include one transmitted electronically via the internet, which bears directly on online-prescriber models. No traveller allowance was located in the Pharmacy Act. | Official |
| Selank | Grey Area | No | No Product Registration Regime | The Bahamas has NO drug marketing-authorisation system. The Pharmacy Act, Ch. 227 (Act No. 8 of 2009) registers people and premises and licenses manufacturers and wholesalers, but does not require a product to be approved before sale - claims that the Bahamas operates drug registration are incorrect. What binds instead: s.27 requires every drug manufactured, offered for sale, imported or exported to meet a pharmacopoeial standard (BP, USP, Ph. Eur., Int. Ph. or another approved by the Minister), with a fine up to BSD 20,000 - a research-grade peptide with no pharmacopoeial monograph fails that test. Section 28 refers import and export control to the Customs Management Act rather than medicines law. Section 33 requires factory and warehouse registration for manufacture or import for storage and wholesale distribution, fine up to BSD 15,000. Note also s.30(5): a prescription expressly does NOT include one transmitted electronically via the internet, which bears directly on online-prescriber models. No traveller allowance was located in the Pharmacy Act. | Official |
| MOTS-c | Grey Area | No | No Product Registration Regime | The Bahamas has NO drug marketing-authorisation system. The Pharmacy Act, Ch. 227 (Act No. 8 of 2009) registers people and premises and licenses manufacturers and wholesalers, but does not require a product to be approved before sale - claims that the Bahamas operates drug registration are incorrect. What binds instead: s.27 requires every drug manufactured, offered for sale, imported or exported to meet a pharmacopoeial standard (BP, USP, Ph. Eur., Int. Ph. or another approved by the Minister), with a fine up to BSD 20,000 - a research-grade peptide with no pharmacopoeial monograph fails that test. Section 28 refers import and export control to the Customs Management Act rather than medicines law. Section 33 requires factory and warehouse registration for manufacture or import for storage and wholesale distribution, fine up to BSD 15,000. Note also s.30(5): a prescription expressly does NOT include one transmitted electronically via the internet, which bears directly on online-prescriber models. No traveller allowance was located in the Pharmacy Act. | Official |
| TB-500 | Grey Area | No | No Product Registration Regime | The Bahamas has NO drug marketing-authorisation system. The Pharmacy Act, Ch. 227 (Act No. 8 of 2009) registers people and premises and licenses manufacturers and wholesalers, but does not require a product to be approved before sale - claims that the Bahamas operates drug registration are incorrect. What binds instead: s.27 requires every drug manufactured, offered for sale, imported or exported to meet a pharmacopoeial standard (BP, USP, Ph. Eur., Int. Ph. or another approved by the Minister), with a fine up to BSD 20,000 - a research-grade peptide with no pharmacopoeial monograph fails that test. Section 28 refers import and export control to the Customs Management Act rather than medicines law. Section 33 requires factory and warehouse registration for manufacture or import for storage and wholesale distribution, fine up to BSD 15,000. Note also s.30(5): a prescription expressly does NOT include one transmitted electronically via the internet, which bears directly on online-prescriber models. No traveller allowance was located in the Pharmacy Act. | Official |
| GHK-Cu | Grey Area | No | No Product Registration Regime | The Bahamas has NO drug marketing-authorisation system. The Pharmacy Act, Ch. 227 (Act No. 8 of 2009) registers people and premises and licenses manufacturers and wholesalers, but does not require a product to be approved before sale - claims that the Bahamas operates drug registration are incorrect. What binds instead: s.27 requires every drug manufactured, offered for sale, imported or exported to meet a pharmacopoeial standard (BP, USP, Ph. Eur., Int. Ph. or another approved by the Minister), with a fine up to BSD 20,000 - a research-grade peptide with no pharmacopoeial monograph fails that test. Section 28 refers import and export control to the Customs Management Act rather than medicines law. Section 33 requires factory and warehouse registration for manufacture or import for storage and wholesale distribution, fine up to BSD 15,000. Note also s.30(5): a prescription expressly does NOT include one transmitted electronically via the internet, which bears directly on online-prescriber models. No traveller allowance was located in the Pharmacy Act. | Official |
| Ipamorelin | Grey Area | No | No Product Registration Regime | The Bahamas has NO drug marketing-authorisation system. The Pharmacy Act, Ch. 227 (Act No. 8 of 2009) registers people and premises and licenses manufacturers and wholesalers, but does not require a product to be approved before sale - claims that the Bahamas operates drug registration are incorrect. What binds instead: s.27 requires every drug manufactured, offered for sale, imported or exported to meet a pharmacopoeial standard (BP, USP, Ph. Eur., Int. Ph. or another approved by the Minister), with a fine up to BSD 20,000 - a research-grade peptide with no pharmacopoeial monograph fails that test. Section 28 refers import and export control to the Customs Management Act rather than medicines law. Section 33 requires factory and warehouse registration for manufacture or import for storage and wholesale distribution, fine up to BSD 15,000. Note also s.30(5): a prescription expressly does NOT include one transmitted electronically via the internet, which bears directly on online-prescriber models. No traveller allowance was located in the Pharmacy Act. | Official |
| Semaglutide | Grey Area | Yes | No Product Registration Regime | The Bahamas has NO drug marketing-authorisation system. The Pharmacy Act, Ch. 227 (Act No. 8 of 2009) registers people and premises and licenses manufacturers and wholesalers, but does not require a product to be approved before sale - claims that the Bahamas operates drug registration are incorrect. What binds instead: s.27 requires every drug manufactured, offered for sale, imported or exported to meet a pharmacopoeial standard (BP, USP, Ph. Eur., Int. Ph. or another approved by the Minister), with a fine up to BSD 20,000 - a research-grade peptide with no pharmacopoeial monograph fails that test. Section 28 refers import and export control to the Customs Management Act rather than medicines law. Section 33 requires factory and warehouse registration for manufacture or import for storage and wholesale distribution, fine up to BSD 15,000. Note also s.30(5): a prescription expressly does NOT include one transmitted electronically via the internet, which bears directly on online-prescriber models. No traveller allowance was located in the Pharmacy Act. | Official |
| CJC-1295 | Grey Area | No | No Product Registration Regime | The Bahamas has NO drug marketing-authorisation system. The Pharmacy Act, Ch. 227 (Act No. 8 of 2009) registers people and premises and licenses manufacturers and wholesalers, but does not require a product to be approved before sale - claims that the Bahamas operates drug registration are incorrect. What binds instead: s.27 requires every drug manufactured, offered for sale, imported or exported to meet a pharmacopoeial standard (BP, USP, Ph. Eur., Int. Ph. or another approved by the Minister), with a fine up to BSD 20,000 - a research-grade peptide with no pharmacopoeial monograph fails that test. Section 28 refers import and export control to the Customs Management Act rather than medicines law. Section 33 requires factory and warehouse registration for manufacture or import for storage and wholesale distribution, fine up to BSD 15,000. Note also s.30(5): a prescription expressly does NOT include one transmitted electronically via the internet, which bears directly on online-prescriber models. No traveller allowance was located in the Pharmacy Act. | Official |
| Semax | Grey Area | No | No Product Registration Regime | The Bahamas has NO drug marketing-authorisation system. The Pharmacy Act, Ch. 227 (Act No. 8 of 2009) registers people and premises and licenses manufacturers and wholesalers, but does not require a product to be approved before sale - claims that the Bahamas operates drug registration are incorrect. What binds instead: s.27 requires every drug manufactured, offered for sale, imported or exported to meet a pharmacopoeial standard (BP, USP, Ph. Eur., Int. Ph. or another approved by the Minister), with a fine up to BSD 20,000 - a research-grade peptide with no pharmacopoeial monograph fails that test. Section 28 refers import and export control to the Customs Management Act rather than medicines law. Section 33 requires factory and warehouse registration for manufacture or import for storage and wholesale distribution, fine up to BSD 15,000. Note also s.30(5): a prescription expressly does NOT include one transmitted electronically via the internet, which bears directly on online-prescriber models. No traveller allowance was located in the Pharmacy Act. | Official |
| BPC-157 | Grey Area | No | No Product Registration Regime | The Bahamas has NO drug marketing-authorisation system. The Pharmacy Act, Ch. 227 (Act No. 8 of 2009) registers people and premises and licenses manufacturers and wholesalers, but does not require a product to be approved before sale - claims that the Bahamas operates drug registration are incorrect. What binds instead: s.27 requires every drug manufactured, offered for sale, imported or exported to meet a pharmacopoeial standard (BP, USP, Ph. Eur., Int. Ph. or another approved by the Minister), with a fine up to BSD 20,000 - a research-grade peptide with no pharmacopoeial monograph fails that test. Section 28 refers import and export control to the Customs Management Act rather than medicines law. Section 33 requires factory and warehouse registration for manufacture or import for storage and wholesale distribution, fine up to BSD 15,000. Note also s.30(5): a prescription expressly does NOT include one transmitted electronically via the internet, which bears directly on online-prescriber models. No traveller allowance was located in the Pharmacy Act. | Official |
| NAD+ | Grey Area | No | No Product Registration Regime | The Bahamas has NO drug marketing-authorisation system. The Pharmacy Act, Ch. 227 (Act No. 8 of 2009) registers people and premises and licenses manufacturers and wholesalers, but does not require a product to be approved before sale - claims that the Bahamas operates drug registration are incorrect. What binds instead: s.27 requires every drug manufactured, offered for sale, imported or exported to meet a pharmacopoeial standard (BP, USP, Ph. Eur., Int. Ph. or another approved by the Minister), with a fine up to BSD 20,000 - a research-grade peptide with no pharmacopoeial monograph fails that test. Section 28 refers import and export control to the Customs Management Act rather than medicines law. Section 33 requires factory and warehouse registration for manufacture or import for storage and wholesale distribution, fine up to BSD 15,000. Note also s.30(5): a prescription expressly does NOT include one transmitted electronically via the internet, which bears directly on online-prescriber models. No traveller allowance was located in the Pharmacy Act. | Official |
| Retatrutide | Grey Area | No | No Product Registration Regime | The Bahamas has NO drug marketing-authorisation system. The Pharmacy Act, Ch. 227 (Act No. 8 of 2009) registers people and premises and licenses manufacturers and wholesalers, but does not require a product to be approved before sale - claims that the Bahamas operates drug registration are incorrect. What binds instead: s.27 requires every drug manufactured, offered for sale, imported or exported to meet a pharmacopoeial standard (BP, USP, Ph. Eur., Int. Ph. or another approved by the Minister), with a fine up to BSD 20,000 - a research-grade peptide with no pharmacopoeial monograph fails that test. Section 28 refers import and export control to the Customs Management Act rather than medicines law. Section 33 requires factory and warehouse registration for manufacture or import for storage and wholesale distribution, fine up to BSD 15,000. Note also s.30(5): a prescription expressly does NOT include one transmitted electronically via the internet, which bears directly on online-prescriber models. No traveller allowance was located in the Pharmacy Act. | Official |
| AOD-9604 | Grey Area | No | No Product Registration Regime | The Bahamas has NO drug marketing-authorisation system. The Pharmacy Act, Ch. 227 (Act No. 8 of 2009) registers people and premises and licenses manufacturers and wholesalers, but does not require a product to be approved before sale - claims that the Bahamas operates drug registration are incorrect. What binds instead: s.27 requires every drug manufactured, offered for sale, imported or exported to meet a pharmacopoeial standard (BP, USP, Ph. Eur., Int. Ph. or another approved by the Minister), with a fine up to BSD 20,000 - a research-grade peptide with no pharmacopoeial monograph fails that test. Section 28 refers import and export control to the Customs Management Act rather than medicines law. Section 33 requires factory and warehouse registration for manufacture or import for storage and wholesale distribution, fine up to BSD 15,000. Note also s.30(5): a prescription expressly does NOT include one transmitted electronically via the internet, which bears directly on online-prescriber models. No traveller allowance was located in the Pharmacy Act. | Official |
| Glutathione | Grey Area | No | No Product Registration Regime | The Bahamas has NO drug marketing-authorisation system. The Pharmacy Act, Ch. 227 (Act No. 8 of 2009) registers people and premises and licenses manufacturers and wholesalers, but does not require a product to be approved before sale - claims that the Bahamas operates drug registration are incorrect. What binds instead: s.27 requires every drug manufactured, offered for sale, imported or exported to meet a pharmacopoeial standard (BP, USP, Ph. Eur., Int. Ph. or another approved by the Minister), with a fine up to BSD 20,000 - a research-grade peptide with no pharmacopoeial monograph fails that test. Section 28 refers import and export control to the Customs Management Act rather than medicines law. Section 33 requires factory and warehouse registration for manufacture or import for storage and wholesale distribution, fine up to BSD 15,000. Note also s.30(5): a prescription expressly does NOT include one transmitted electronically via the internet, which bears directly on online-prescriber models. No traveller allowance was located in the Pharmacy Act. | Official |
| DSIP | Grey Area | No | No Product Registration Regime | The Bahamas has NO drug marketing-authorisation system. The Pharmacy Act, Ch. 227 (Act No. 8 of 2009) registers people and premises and licenses manufacturers and wholesalers, but does not require a product to be approved before sale - claims that the Bahamas operates drug registration are incorrect. What binds instead: s.27 requires every drug manufactured, offered for sale, imported or exported to meet a pharmacopoeial standard (BP, USP, Ph. Eur., Int. Ph. or another approved by the Minister), with a fine up to BSD 20,000 - a research-grade peptide with no pharmacopoeial monograph fails that test. Section 28 refers import and export control to the Customs Management Act rather than medicines law. Section 33 requires factory and warehouse registration for manufacture or import for storage and wholesale distribution, fine up to BSD 15,000. Note also s.30(5): a prescription expressly does NOT include one transmitted electronically via the internet, which bears directly on online-prescriber models. No traveller allowance was located in the Pharmacy Act. | Official |
| Epithalon | Grey Area | No | No Product Registration Regime | The Bahamas has NO drug marketing-authorisation system. The Pharmacy Act, Ch. 227 (Act No. 8 of 2009) registers people and premises and licenses manufacturers and wholesalers, but does not require a product to be approved before sale - claims that the Bahamas operates drug registration are incorrect. What binds instead: s.27 requires every drug manufactured, offered for sale, imported or exported to meet a pharmacopoeial standard (BP, USP, Ph. Eur., Int. Ph. or another approved by the Minister), with a fine up to BSD 20,000 - a research-grade peptide with no pharmacopoeial monograph fails that test. Section 28 refers import and export control to the Customs Management Act rather than medicines law. Section 33 requires factory and warehouse registration for manufacture or import for storage and wholesale distribution, fine up to BSD 15,000. Note also s.30(5): a prescription expressly does NOT include one transmitted electronically via the internet, which bears directly on online-prescriber models. No traveller allowance was located in the Pharmacy Act. | Official |
| KPV | Grey Area | No | No Product Registration Regime | The Bahamas has NO drug marketing-authorisation system. The Pharmacy Act, Ch. 227 (Act No. 8 of 2009) registers people and premises and licenses manufacturers and wholesalers, but does not require a product to be approved before sale - claims that the Bahamas operates drug registration are incorrect. What binds instead: s.27 requires every drug manufactured, offered for sale, imported or exported to meet a pharmacopoeial standard (BP, USP, Ph. Eur., Int. Ph. or another approved by the Minister), with a fine up to BSD 20,000 - a research-grade peptide with no pharmacopoeial monograph fails that test. Section 28 refers import and export control to the Customs Management Act rather than medicines law. Section 33 requires factory and warehouse registration for manufacture or import for storage and wholesale distribution, fine up to BSD 15,000. Note also s.30(5): a prescription expressly does NOT include one transmitted electronically via the internet, which bears directly on online-prescriber models. No traveller allowance was located in the Pharmacy Act. | Official |
| HGH | Grey Area | No | No Product Registration Regime | The Bahamas has NO drug marketing-authorisation system. The Pharmacy Act, Ch. 227 (Act No. 8 of 2009) registers people and premises and licenses manufacturers and wholesalers, but does not require a product to be approved before sale - claims that the Bahamas operates drug registration are incorrect. What binds instead: s.27 requires every drug manufactured, offered for sale, imported or exported to meet a pharmacopoeial standard (BP, USP, Ph. Eur., Int. Ph. or another approved by the Minister), with a fine up to BSD 20,000 - a research-grade peptide with no pharmacopoeial monograph fails that test. Section 28 refers import and export control to the Customs Management Act rather than medicines law. Section 33 requires factory and warehouse registration for manufacture or import for storage and wholesale distribution, fine up to BSD 15,000. Note also s.30(5): a prescription expressly does NOT include one transmitted electronically via the internet, which bears directly on online-prescriber models. No traveller allowance was located in the Pharmacy Act. | Official |
| Liraglutide | Grey Area | No | No Product Registration Regime | The Bahamas has NO drug marketing-authorisation system. The Pharmacy Act, Ch. 227 (Act No. 8 of 2009) registers people and premises and licenses manufacturers and wholesalers, but does not require a product to be approved before sale - claims that the Bahamas operates drug registration are incorrect. What binds instead: s.27 requires every drug manufactured, offered for sale, imported or exported to meet a pharmacopoeial standard (BP, USP, Ph. Eur., Int. Ph. or another approved by the Minister), with a fine up to BSD 20,000 - a research-grade peptide with no pharmacopoeial monograph fails that test. Section 28 refers import and export control to the Customs Management Act rather than medicines law. Section 33 requires factory and warehouse registration for manufacture or import for storage and wholesale distribution, fine up to BSD 15,000. Note also s.30(5): a prescription expressly does NOT include one transmitted electronically via the internet, which bears directly on online-prescriber models. No traveller allowance was located in the Pharmacy Act. | Official |
| Melanotan II | Grey Area | No | No Product Registration Regime | The Bahamas has NO drug marketing-authorisation system. The Pharmacy Act, Ch. 227 (Act No. 8 of 2009) registers people and premises and licenses manufacturers and wholesalers, but does not require a product to be approved before sale - claims that the Bahamas operates drug registration are incorrect. What binds instead: s.27 requires every drug manufactured, offered for sale, imported or exported to meet a pharmacopoeial standard (BP, USP, Ph. Eur., Int. Ph. or another approved by the Minister), with a fine up to BSD 20,000 - a research-grade peptide with no pharmacopoeial monograph fails that test. Section 28 refers import and export control to the Customs Management Act rather than medicines law. Section 33 requires factory and warehouse registration for manufacture or import for storage and wholesale distribution, fine up to BSD 15,000. Note also s.30(5): a prescription expressly does NOT include one transmitted electronically via the internet, which bears directly on online-prescriber models. No traveller allowance was located in the Pharmacy Act. | Official |
| MK-677 | Grey Area | No | No Product Registration Regime | The Bahamas has NO drug marketing-authorisation system. The Pharmacy Act, Ch. 227 (Act No. 8 of 2009) registers people and premises and licenses manufacturers and wholesalers, but does not require a product to be approved before sale - claims that the Bahamas operates drug registration are incorrect. What binds instead: s.27 requires every drug manufactured, offered for sale, imported or exported to meet a pharmacopoeial standard (BP, USP, Ph. Eur., Int. Ph. or another approved by the Minister), with a fine up to BSD 20,000 - a research-grade peptide with no pharmacopoeial monograph fails that test. Section 28 refers import and export control to the Customs Management Act rather than medicines law. Section 33 requires factory and warehouse registration for manufacture or import for storage and wholesale distribution, fine up to BSD 15,000. Note also s.30(5): a prescription expressly does NOT include one transmitted electronically via the internet, which bears directly on online-prescriber models. No traveller allowance was located in the Pharmacy Act. | Official |
| Vitamin B12 | Grey Area | No | No Product Registration Regime | The Bahamas has NO drug marketing-authorisation system. The Pharmacy Act, Ch. 227 (Act No. 8 of 2009) registers people and premises and licenses manufacturers and wholesalers, but does not require a product to be approved before sale - claims that the Bahamas operates drug registration are incorrect. What binds instead: s.27 requires every drug manufactured, offered for sale, imported or exported to meet a pharmacopoeial standard (BP, USP, Ph. Eur., Int. Ph. or another approved by the Minister), with a fine up to BSD 20,000 - a research-grade peptide with no pharmacopoeial monograph fails that test. Section 28 refers import and export control to the Customs Management Act rather than medicines law. Section 33 requires factory and warehouse registration for manufacture or import for storage and wholesale distribution, fine up to BSD 15,000. Note also s.30(5): a prescription expressly does NOT include one transmitted electronically via the internet, which bears directly on online-prescriber models. No traveller allowance was located in the Pharmacy Act. | Official |
| PT-141 | Grey Area | No | No Product Registration Regime | The Bahamas has NO drug marketing-authorisation system. The Pharmacy Act, Ch. 227 (Act No. 8 of 2009) registers people and premises and licenses manufacturers and wholesalers, but does not require a product to be approved before sale - claims that the Bahamas operates drug registration are incorrect. What binds instead: s.27 requires every drug manufactured, offered for sale, imported or exported to meet a pharmacopoeial standard (BP, USP, Ph. Eur., Int. Ph. or another approved by the Minister), with a fine up to BSD 20,000 - a research-grade peptide with no pharmacopoeial monograph fails that test. Section 28 refers import and export control to the Customs Management Act rather than medicines law. Section 33 requires factory and warehouse registration for manufacture or import for storage and wholesale distribution, fine up to BSD 15,000. Note also s.30(5): a prescription expressly does NOT include one transmitted electronically via the internet, which bears directly on online-prescriber models. No traveller allowance was located in the Pharmacy Act. | Official |
Data is researcher-verified but not legal advice. Always consult local regulations before purchasing, importing, or traveling with peptides. Last verified: 2026-02-28.